|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Pan Y and Claret FX: Targeting Jab1/CSN5
in nasopharyngeal carcinoma. Cancer Lett. 326:155–160. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tao Q and Chan AT: Nasopharyngeal
carcinoma: molecular pathogenesis and therapeutic developments.
Expert Rev Mol Med. 9:1–24. 2007.PubMed/NCBI
|
|
4
|
Erkal HS, Serin M and Cakmak A:
Nasopharyngeal carcinomas: analysis of patient, tumor and treatment
characteristics determining outcome. Radiother Oncol. 61:247–256.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O’Sullivan B: Nasopharynx cancer:
therapeutic value of chemoradiotherapy. Int J Radiat Oncol Biol
Phys. 69(Suppl 2): S118–S121. 2007.PubMed/NCBI
|
|
6
|
Jang M, Cai L, Udeani GO, et al: Cancer
chemopreventive activity of resveratrol, a natural product derived
from grapes. Science. 275:218–220. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aggarwal BB and Shishodia S: Molecular
targets of dietary agents for prevention and therapy of cancer.
Biochem Pharmacol. 71:1397–1421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tyihak E, Kiraly-Veghely Z and Moricz AM:
Multiple beneficial effects of resveratrol and their
chemical-biochemical basis. Nat Prod Commun. 6:631–638.
2011.PubMed/NCBI
|
|
9
|
Yu W, Fu YC and Wang W: Cellular and
molecular effects of resveratrol in health and disease. J Cell
Biochem. 113:752–759. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang M, Li X, Zhang Y and Zhou K: Bax
inhibitor-1 mediates apoptosis-resistance in human nasopharyngeal
carcinoma cells. Mol Cell Biochem. 333:1–7. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nys K, Maes H, Dudek AM and Agostinis P:
Uncovering the role of hypoxia inducible factor-1alpha in skin
carcinogenesis. Biochim Biophys Acta. 1816:1–12. 2011.PubMed/NCBI
|
|
12
|
Castaneda CA, Cortes-Funes H, Gomez HL and
Ciruelos EM: The phosphatidyl inositol 3-kinase/AKT signaling
pathway in breast cancer. Cancer Metastasis Rev. 29:751–759. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Patel KR, Scott E, Brown VA, Gescher AJ,
Steward WP and Brown K: Clinical trials of resveratrol. Ann NY Acad
Sci. 1215:161–169. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schneider Y, Vincent F, Duranton B, et al:
Anti-proliferative effect of resveratrol, a natural component of
grapes and wine, on human colonic cancer cells. Cancer Lett.
158:85–91. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin HY, Tang HY, Davis FB and Davis PJ:
Resveratrol and apoptosis. Ann NY Acad Sci. 1215:79–88. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aziz MH, Nihal M, Fu VX, Jarrard DF and
Ahmad N: Resveratrol-caused apoptosis of human prostate carcinoma
LNCaP cells is mediated via modulation of phosphatidylinositol
3′-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther.
5:1335–1341. 2006.PubMed/NCBI
|
|
18
|
Kuo PL, Chiang LC and Lin CC:
Resveratrol-induced apoptosis is mediated by p53-dependent pathway
in Hep G2 cells. Life Sci. 72:23–34. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Notas G, Nifli AP, Kampa M, Vercauteren J,
Kouroumalis E and Castanas E: Resveratrol exerts its
anti-proliferative effect on HepG2 hepatocellular carcinoma cells,
by inducing cell cycle arrest, and NOS activation. Biochim Biophys
Acta. 1760:1657–1666. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kotha A, Sekharam M, Cilenti L, et al:
Resveratrol inhibits Src and Stat3 signaling and induces the
apoptosis of malignant cells containing activated Stat3 protein.
Mol Cancer Ther. 5:621–629. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Joe AK, Liu H, Suzui M, Vural ME, Xiao D
and Weinstein IB: Resveratrol induces growth inhibition, S-phase
arrest, apoptosis, and changes in biomarker expression in several
human cancer cell lines. Clin Cancer Res. 8:893–903.
2002.PubMed/NCBI
|
|
22
|
Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J
and Le AD: Resveratrol inhibits hypoxia-induced accumulation of
hypoxiainducible factor-1alpha and VEGF expression in human tongue
squamous cell carcinoma and hepatoma cells. Mol Cancer Ther.
4:1465–1474. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Salado C, Olaso E, Gallot N, et al:
Resveratrol prevents inflammation-dependent hepatic melanoma
metastasis by inhibiting the secretion and effects of
interleukin-18. J Transl Med. 9:592011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Casanova F, Quarti J, da Costa DC, Ramos
CA, da Silva JL and Fialho E: Resveratrol chemosensitizes breast
cancer cells to melphalan by cell cycle arrest. J Cell Biochem.
113:2586–2596. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fang Y, DeMarco VG and Nicholl MB:
Resveratrol enhances radiation sensitivity in prostate cancer by
inhibiting cell proliferation and promoting cell senescence and
apoptosis. Cancer Sci. 103:1090–1098. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iqbal MA and Bamezai RN: Resveratrol
inhibits cancer cell metabolism by down regulating pyruvate kinase
M2 via inhibition of mammalian target of rapamycin. PLoS One.
7:e367642012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Whitlock NC and Baek SJ: The anticancer
effects of resveratrol: modulation of transcription factors. Nutr
Cancer. 64:493–502. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
She QB, Bode AM, Ma WY, Chen NY and Dong
Z: Resveratrol-induced activation of p53 and apoptosis is mediated
by extracellular-signal-regulated protein kinases and p38 kinase.
Cancer Res. 61:1604–1610. 2001.PubMed/NCBI
|
|
29
|
Shih A, Davis FB, Lin HY and Davis PJ:
Resveratrol induces apoptosis in thyroid cancer cell lines via a
MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab.
87:1223–1232. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pozo-Guisado E, Lorenzo-Benayas MJ and
Fernandez-Salguero PM: Resveratrol modulates the phosphoinositide
3-kinase pathway through an estrogen receptor alpha-dependent
mechanism: relevance in cell proliferation. Int J Cancer.
109:167–173. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang YP, Chang YL, Huang PI, et al:
Resveratrol suppresses tumorigenicity and enhances radiosensitivity
in primary glioblastoma tumor initiating cells by inhibiting the
STAT3 axis. J Cell Physiol. 227:976–993. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen HJ, Hsu LS, Shia YT, Lin MW and Lin
CM: The β-catenin/TCF complex as a novel target of resveratrol in
the Wnt/β-catenin signaling pathway. Biochem Pharmacol.
84:1143–1153. 2012.
|
|
33
|
Quan F, Zhang SQ, Bai YX, et al:
Resveratrol increases sensitivity of CNE2 cells to chemotherapeutic
drugs under hypoxia. Zhong Xi Yi Jie He Xue Bao. 7:952–957.
2009.(In Chinese).
|
|
34
|
Chow SE, Wang JS, Chuang SF, et al:
Resveratrol-induced p53-independent apoptosis of human
nasopharyngeal carcinoma cells is correlated with the
downregulation of ΔNp63. Cancer Gene Ther. 17:872–882.
2010.PubMed/NCBI
|
|
35
|
Huang TT, Lin HC, Chen CC, et al:
Resveratrol induces apoptosis of human nasopharyngeal carcinoma
cells via activation of multiple apoptotic pathways. J Cell
Physiol. 226:720–728. 2011. View Article : Google Scholar
|
